Filing status
- Accounts due
- 31 January 2028
- Last accounts
- 31 July 2026
- Conf. stmt due
- 13 February 2027
- Last conf. stmt
- 30 January 2026
Infex Therapeutics Holdings PLC
- Incorporated
- 15 February 2022 (4 years)
- Industry
- Activities of other holding companies n.e.c. (64209)
- Owned by
- Jonathan Paul Moulton
- Accounts type
- Full
- Region
- Greater London
- Address
- 1 Bow ChurchyardLondonEC4M 9DQ
Charges
- Total
- 2
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 2
Officers 5 active
Officer details are public data from the Companies House register.
Irish
Born July 1967 (59)
Jackson, Peter, Dr
Secretary · Appointed 5 May 2022
Director · Appointed 6 April 2022
Also at Infex Therapeutics Limited · more companies
British
Born March 1961 (65)
Director · Appointed 6 April 2022
British
Born October 1950 (76)
Jackson, Peter, Dr
Director · Appointed 15 February 2022
British
Born February 1963 (63)
Officer history (1 former)
1 February 2023
12 May 2022
5 May 2022
Appointed Jackson, Peter, Dr as Secretary
6 April 2022
6 April 2022
6 April 2022
15 February 2022
Appointed Jackson, Peter, Dr as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Individual · Notified 6 April 2022
Owns 75–100% of shares
Holds 75–100% of voting rights
British
Born October 1950 (76)
Holdings 1
Companies where Infex Therapeutics Holdings PLC is registered as a person with significant control
Owns 75–100% of shares
Active
Former controllers (2)
13 June 2023
Ceased Catapult Life Sciences GP LLP — Owns 25–50% of shares
6 April 2022
Ceased Peter Jackson — Owns 75–100% of shares
Financials
Figures from 2025 accounts. Newer accounts, made up to 31 July 2026, are filed but not read yet. See them on Companies House
- Cash
- £1,416,976
- Turnover
- £0
- Profit Before Tax
- (£17,467,729)
- Current Ratio
- 2.0x
- Return on Equity
- -998%
Trend
Turnover
Balance sheet detail
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Current Assets | £3,358,443 | £10,992,501 | |
| Debtors | £1,941,467 | £10,387,989 | |
| Cash | £1,416,976 | £604,512 | |
| Creditors (< 1 year) | £1,662,456 | £8,429,775 | £3,450 |
| Creditors (> 1 year) | £0 | £3,917,953 | |
| Net Current Assets | £1,695,987 | £2,562,726 | |
| Net Assets | £2,617,652 | ||
| Shareholder Funds | £1,750,913 | £2,617,652 | |
| Turnover | £0 | £0 | |
| Admin Expenses | £6,247,160 | £1,448,179 | |
| Operating Profit | (£6,247,160) | (£1,448,179) | |
| Profit Before Tax | (£17,467,729) | (£419,342) | |
| Tax | £0 | £0 | |
| Profit for Period | (£17,467,729) | (£419,342) | |
Filings 67
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 4 November 2026 | Full accounts | 31 July 2026 | ||
| 24 March 2026 | Memorandum and Articles of Association | |||
| 24 March 2026 | Resolutions | |||
| 12 March 2026 | Statement of capital following an allotment of shares | |||
| 11 February 2026 | Confirmation statement with updates | 30 January 2026 |
Some other companies at this address
Other companies in this industry
Wellingborough
London
Markfield
London
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →